Viewing Study NCT06225427


Ignite Creation Date: 2025-12-25 @ 5:18 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
Study NCT ID: NCT06225427
Status: RECRUITING
Last Update Posted: 2025-10-17
First Post: 2024-01-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Gilteritinib for the Treatment of ALK NSCLC
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module